Notice more hair on your brush, comb, or shower drain? A 2015 IFOP survey found that 76% of non-balding French adults reported hair loss. By age 65, 30% of men experience androgenetic alopecia. Both men and women often see reduced hair density with age. Decades of research have pinpointed stem cells as the most promising avenue for understanding and treating this issue.
Hair transplants can be costly and invasive. Medications like finasteride for men's androgenetic alopecia may cause side effects such as reduced libido or erectile dysfunction, while minoxidil can lead to unwanted hair growth elsewhere. Researchers are now turning to stem cell-based alternatives for safer, more effective solutions.
For years, studies targeted keratinocytes, the building blocks of skin and hair follicles. But a University of Calgary research team shifted focus to a key group in hair follicles and skin stem cells: fibroblasts. Their findings identify these as the primary drivers of age-related hair loss.
Examining thinning hair in aged mice, the team discovered that fibroblast stem cells had lost their regenerative ability. "There weren't enough to regenerate fibroblasts," explains lead researcher Jeff Biernaskie. "As a result, fibroblasts and hair follicles miniaturized, halting hair production."
Fibroblasts are crucial: they signal keratinocytes to divide, driving hair follicle growth cycles and new hair formation. When fibroblast numbers dwindle, this signal weakens, stalling the process. As Biernaskie notes, "To prevent hair loss or regrow hair, we must preserve these stem cells' function in hair follicles."
This discovery refines hair loss research directions. The Calgary team aims to halt degeneration by targeting genetic mutations in fibroblast stem cells.
Lead author Wisoo Shin highlights wider potential: similar fibroblasts exist in most organs, supporting tissue integrity and regeneration. Enhancing their self-renewal into old age could treat injuries and boost skin repair.
